Embr turns perimenopause symptoms into clinical-grade evidence your GP can act on. Built for women in high-performance careers who need answers, not a wellness app.
Built for women in consulting, finance, and tech. No spam.
For millions of high-performing women, perimenopause arrives silently and without the tools to understand or prove it.
In March 2026 we surveyed senior professional women across finance, consulting, technology, and more. Here is what they told us.
Embr bridges the gap between your lived symptom experience and the clinical language your GP needs to act on it.
Embr is grounded in research across endocrinology, cognitive performance, and behavioural science. Complex biology translated into precise, actionable intelligence.
60% of the women we surveyed want their employer to cover the cost of perimenopause support. The demand exists. The infrastructure is now here.
Embr is in development. Join the waitlist for early access. Your symptoms deserve structure. Your GP deserves evidence. You deserve answers.
Limited early access spots. No spam. Unsubscribe any time.